Director, Global Product Strategy - Lung Cancer Therapies

Role Summary

Director, Lung Cancer Portfolio, reporting to the VP of Lung Cancer Therapies, based in New Jersey, US. This strategic, science-driven leader shapes the future of a high-priority oncology indication, focusing on new product planning and early commercial strategy. The role requires hands-on leadership, deep oncology market insight, and the ability to position early assets for future success in a global environment, with presence in the US and Germany.

• Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy
• Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability
• Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions
• Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement
• Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts
• Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership
• Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

• Required:
  
  A minimum of 8 years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles
• Required:
  
  Strong track record in solid tumors, ideally with direct or adjacent lung cancer experience
• Required:
  
  Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy
• Required:
  
  Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development
• Required:
  
  Demonstrated understanding of the US oncology landscape and stakeholder needs; experience & understanding with EU and other major markets
• Required:
  
  Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment
• Required:
  
  Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies
• Preferred:
  Advanced degree (PhD, Pharm
  
  D, MD, or MBA) strongly preferred